JPRN-UMIN000008756招募中未知
Abatacept-based approach to cure of RA - ACURE study
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 40 人开始时间: 2012年8月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable(—)
- 性别
- Female
入选标准
- 未提供
排除标准
- •1,Contraindication with abatacept 2, Patients treated with abatacept 3, Using PSL, plasma pheresis, joint replacement and other surgical treatment 4 Chronic active EBV infection 5,Chronic HBV infection 6, Infection 7, Patients who are pregnant, who are nursing or who hope to be pregnant 8, Patients who are inadequate by investigator's decision.
研究者
相似试验
招募中
不适用
Efficacy and safety of abatacept in RA patients in daily clinical practice: An retrospective observational study Orencia as Biological Intensive Treatment for RARheumatoid ArthritisJPRN-UMIN000008578niversity of Occupational and Environmental Health, Japan100
已完成
不适用
Efficacy and safety of abatacept in RA patients in daily clinical practice: An retrospective observational studyRheumatoid ArthritisJPRN-UMIN000008285niversity of Occupational and Environmental Health, Japan50
进行中(未招募)
1 期
Safety of abatacept in Rheumatoid Arthritis associated Interstitial Lung DiseaseRheumatoid-associated Interstitial Lung Disease (RA-ILD)MedDRA version: 20.0Level: PTClassification code 10022611Term: Interstitial lung diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.0Level: LLTClassification code 10003268Term: Arthritis rheumatoidSystem Organ Class: 100000004859EUCTR2016-002569-68-GBCambridge University Hospitals NHS Foundation Trust30
Unknown
2 期
APRIL (AbatacePt in Rheumatoid Arthritis-ILD)Rheumatoid ArthritisInterstitial Lung DiseaseNCT03084419Cambridge University Hospitals NHS Foundation Trust30
终止
不适用
Bone MicroArchitecture Abatacept (BMA2)Arthritis, RheumatoidNCT02675218Centre Hospitalier Universitaire de Saint Etienne13
